X-91876958-A-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_032968.5(PCDH11X):c.718A>T(p.Thr240Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000252 in 1,208,038 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 99 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_032968.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PCDH11X | NM_032968.5 | c.718A>T | p.Thr240Ser | missense_variant | 6/11 | ENST00000682573.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PCDH11X | ENST00000682573.1 | c.718A>T | p.Thr240Ser | missense_variant | 6/11 | NM_032968.5 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000300 AC: 33AN: 109904Hom.: 0 Cov.: 20 AF XY: 0.000156 AC XY: 5AN XY: 32084
GnomAD3 exomes AF: 0.000229 AC: 42AN: 183292Hom.: 0 AF XY: 0.000162 AC XY: 11AN XY: 67862
GnomAD4 exome AF: 0.000247 AC: 271AN: 1098091Hom.: 0 Cov.: 31 AF XY: 0.000259 AC XY: 94AN XY: 363565
GnomAD4 genome AF: 0.000300 AC: 33AN: 109947Hom.: 0 Cov.: 20 AF XY: 0.000156 AC XY: 5AN XY: 32137
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.718A>T (p.T240S) alteration is located in exon 2 (coding exon 2) of the PCDH11X gene. This alteration results from a A to T substitution at nucleotide position 718, causing the threonine (T) at amino acid position 240 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at